Skip to main content
. 2024 May 7;11(26):2401617. doi: 10.1002/advs.202401617

Figure 6.

Figure 6

a) Schematic illustration of the tetrahedral structure loaded with AS1411 in order to release siRNA in malignant melanoma. Reproduced with permission from.[ 85 ] Copyright 2021, American Chemical Society. b) (A) Antitumor therapy of TDN‐FA/PL1/Pcsk9 siRNA via nanoplatform separated, delivered the Pcsk9 siRNA in tumor, and decreasing PCSK9‐mediated MHC I degradation. (B) Body weight of mouse. (C) different mice tumors photo. Reproduced with permission from.[ 86 ] Copyright 2022, American Chemical Society.